Last $1.89 USD
Change Today +0.15 / 8.62%
Volume 1.2M
PRAN On Other Exchanges
Symbol
Exchange
NASDAQ CM
Berlin
Stuttgart
OTC US
As of 8:10 PM 04/17/14 All times are local (Market data is delayed by at least 15 minutes).
text size: T | T
Back to Snapshot
Company Description

Contact Info

369 Royal Parade

Level 2

Parkville, VIC 3052

Australia

Phone: 61 3 9349 4906

Fax: 61 3 9348 0377

Prana Biotechnology Limited, a development stage company, is engaged in the research and development of therapeutic drugs designed to treat the underlying cause of degeneration of the brain and the eye as the aging process progresses. Platform Technology and Research Programs The company’s platform technology addresses the causes of a spectrum of neurodegenerative and age-related diseases based on the interrelationship of metals and proteins. Its research efforts have been directed at research into potential therapeutics for the treatment of Alzheimer’s disease, Huntington’s disease, and Parkinson’s disease. The company’s platform technology might also be applicable for certain cancers; age-related macular degeneration; Motor Neuron disease; Creutzfeldt-Jakob disease; age-related cataracts; and other neurodegenerative diseases. The company has initiated a program of research into the potential use of selected metal protein attenuating compounds from its library for use in the treatment of brain cancer, in particular the prevalent and deadly form of the disease, Glioblastoma Multiforme. Its scientists have developed a pipeline of compounds across multiple chemical classes that target the interaction of specific metals and certain aggregating proteins, such as beta-amyloid. PBT2, the company’s Alzheimer’s and Huntington’s disease lead metal protein attenuating compound product candidate and PBT434, its candidate lead compound for Parkinson’s disease and movement disorders are selected from the ‘rationally designed’ pipeline. Regulatory Considerations The company’s ongoing research and development activities are subject to regulation by human research ethics committees and institutional research boards, as well as various governmental authorities in Australia, principally the Therapeutics Goods Administration, the Food and Drug Administration in the United States, the Medicines and Healthcare products Regulatory Agency in the United Kingdom, and the European Medicines Agency. History Prana Biotechnology Limited was founded in 1997. The company was incorporated under the laws of the Commonwealth of Australia in 1997.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
PRAN:US $1.89 USD +0.15

PRAN Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for PRAN.
View Industry Companies
 

Industry Analysis

PRAN

Industry Average

Valuation PRAN Industry Range
Price/Earnings NM Not Meaningful
Price/Sales 19.6x
Price/Book 4.1x
Price/Cash Flow NM Not Meaningful
TEV/Sales 18.7x
 | 

Post a JobJobs

View all jobs

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact PRANA BIOTECHNOLOGY LTD-ADR, please visit www.pranabio.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.